IL6 and cryptococcosis: Further studies investigating the impact of immunomodulator molecules such as IL-6 on cerebral cryptococcosis are warranted for the development of antifungal therapy or treatments aimed to prevent, reduce, or manage Cn infections especially in at-risk immunosuppressed populations.